Hedgehog/GLI Signaling Activates Suppressor of Cytokine Signaling 1 (SOCS1) in Epidermal and Neural Tumor Cells

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Laner Plamberger, Sandra ^a,b   Wolff, Florian ^a   Kaser Eichberger, Alexandra ^a,c   Swierczynski, Stefan ^b   Hauser Kronberger, Cornelia ^b   Frischauf, Anna Maria ^a   Eichberger, Thomas ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; SHORT HAIRPIN RNA; SONIC HEDGEHOG PROTEIN; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR GLI2;

APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE ARREST; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPIDERMIS CELL; GENE ACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; INHIBITION KINETICS; KERATINOCYTE; MEDULLOBLASTOMA; NERVE CELL; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SKIN CANCER; TUMOR IMMUNITY;

CELL LINE, TUMOR; HEDGEHOG PROTEINS; HUMANS; INTERFERON-GAMMA; KERATINOCYTES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MEDULLOBLASTOMA; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHOSPHORYLATION; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION FACTORS;

EID: 84883762731     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075317     Document Type: Article

References (75)

1. Barakat MT, Humke EW, Scott MP, (2010) Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer. Trends Mol Med 16: 337-348. doi:10.1016/j.molmed.2010.05.003. PubMed: 20696410.
2. Ng JM, Curran T, (2011) The Hedgehog's tale: developing strategies for targeting cancer. Nat Rev Cancer 11: 493-501. doi:10.1038/nrc3079. PubMed: 21614026.
3. Ingham PW, Nakano Y, Seger C, (2011) Mechanisms and functions of Hedgehog signalling across the metazoa. Nat Rev Genet 12: 393-406. doi:10.1038/nrg2984. PubMed: 21502959.
4. Cohen Jr MM, (2010) Hedgehog signaling update. Am J Med Genet A 152A: 1875-1914. doi:10.1002/ajmg.a.32909. PubMed: 20635334.
5. Gallet A, (2011) Hedgehog morphogen: from secretion to reception. Trends Cell Biol 21: 238-246. doi:10.1016/j.tcb.2010.12.005. PubMed: 21257310.
6. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, et al. (1996) Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272: 1668-1671. doi:10.1126/science.272.5268.1668. PubMed: 8658145.
7. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, et al. (1996) Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85: 841-851. doi:10.1016/S0092-8674(00)81268-4. PubMed: 8681379.
8. Reifenberger J, Wolter M, Knobbe CB, Köhler B, Schönicke A, et al. (2005) Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol 152: 43-51. doi:10.1111/j.1365-2133.2005.06353.x. PubMed: 15656799.
9. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, et al. (1998) Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391: 90-92. doi:10.1038/34201. PubMed: 9422511.
10. Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, et al. (2002) Mutations in SUFU predispose to medulloblastoma. Nat Genet 31: 306-310. doi:10.1038/ng916. PubMed: 12068298.
11. Oro AE, Higgins KM, Hu Z, Bonifas JM, Epstein Jr EH, et al. (1997) Basal cell carcinomas in mice overexpressing sonic hedgehog. Science 276: 817-821. doi:10.1126/science.276.5313.817. PubMed: 9115210.
12. Nilsson M, Undèn AB, Krause D, Malmqwist U, Raza K, et al. (2000) Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc Natl Acad Sci U S A 97: 3438-3443. doi:10.1073/pnas.97.7.3438. PubMed: 10725363.
13. Grachtchouk M, Mo R, Yu S, Zhang X, Sasaki H, et al. (2000) Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat Genet 24: 216-217. doi:10.1038/73417. PubMed: 10700170.
14. Kasper M, Schnidar H, Neill GW, Hanneder M, Klingler S, et al. (2006) Selective modulation of Hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytes. Mol Cell Biol 26: 6283-6298. doi:10.1128/MCB.02317-05. PubMed: 16880536.
15. Fan Q, He M, Sheng T, Zhang X, Sinha M, et al. (2010) Requirement of TGFbeta signaling for SMO-mediated carcinogenesis. J Biol Chem 285: 36570-36576. doi:10.1074/jbc.C110.164442. PubMed: 20858897.
16. Shin K, Lee J, Guo N, Kim J, Lim A, et al. (2011) Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 472: 110-114. doi:10.1038/nature09851. PubMed: 21389986.
17. Schreck KC, Taylor P, Marchionni L, Gopalakrishnan V, Bar EE, et al. (2010) The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Clin Cancer Res 16: 6060-6070. doi:10.1158/1078-0432.CCR-10-1624. PubMed: 21169257.
18. Noubissi FK, Goswami S, Sanek NA, Kawakami K, Minamoto T, et al. (2009) Wnt signaling stimulates transcriptional outcome of the Hedgehog pathway by stabilizing GLI1 mRNA. Cancer Res 69: 8572-8578. doi:10.1158/0008-5472.CAN-09-1500. PubMed: 19887615.
19. Todoric J, Strobl B, Jais A, Boucheron N, Bayer M, et al. (2011) Cross-talk between interferon-gamma and hedgehog signaling regulates adipogenesis. Diabetes 60: 1668-1676. doi:10.2337/db10-1628. PubMed: 21536945.
20. Wang J, Lin W, Popko B, Campbell IL, (2004) Inducible production of interferon-gamma in the developing brain causes cerebellar dysplasia with activation of the Sonic hedgehog pathway. Mol Cell Neurosci 27: 489-496. doi:10.1016/j.mcn.2004.08.004. PubMed: 15555926.
21. Sun L, Tian Z, Wang J, (2010) A direct cross-talk between interferon-gamma and sonic hedgehog signaling that leads to the proliferation of neuronal precursor cells. Brain Behav Immun 24: 220-228. doi:10.1016/j.bbi.2009.09.016. PubMed: 19800966.
22. Alexander WS, (2002) Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2: 410-416. PubMed: 12093007.
23. Yoshimura A, Naka T, Kubo M, (2007) SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7: 454-465. doi:10.1038/nri2093. PubMed: 17525754.
24. Linossi EM, Babon JJ, Hilton DJ, Nicholson SE, (2013) Suppression of cytokine signaling: The SOCS perspective. Cytokine Growth Factor Rev, 24: 241-8. PubMed: 23545160.
25. Croker BA, Kiu H, Nicholson SE, (2008) SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol 19: 414-422. doi:10.1016/j.semcdb.2008.07.010. PubMed: 18708154.
26. Ilangumaran S, Rottapel R, (2003) Regulation of cytokine receptor signaling by SOCS1. Immunol Rev 192: 196-211. doi:10.1034/j.1600-065X.2003.00020.x. PubMed: 12670405.
27. Yoshimura A, Suzuki M, Sakaguchi R, Hanada T, Yasukawa H, (2012) SOCS, Inflammation, and Autoimmunity. Front Immunol 3: 20. PubMed: 22566904.
28. Alexander WS, Starr R, Fenner JE, Scott CL, Handman E, et al. (1999) SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98: 597-608. doi:10.1016/S0092-8674(00)80047-1. PubMed: 10490099.
29. Marine JC, Topham DJ, McKay C, Wang D, Parganas E, et al. (1999) SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98: 609-616. doi:10.1016/S0092-8674(00)80048-3. PubMed: 10490100.
30. Yu CR, Mahdi RR, Oh HM, Amadi-Obi A, Levy-Clarke G, et al. (2011) Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation. Invest Ophthalmol Vis Sci 52: 6978-6986. doi:10.1167/iovs.11-7688. PubMed: 21778271.
31. Chong MM, Chen Y, Darwiche R, Dudek NL, Irawaty W, et al. (2004) Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction. J Immunol 172: 5714-5721. PubMed: 15100317.
32. Fujimoto M, Naka T, Nakagawa R, Kawazoe Y, Morita Y, et al. (2000) Defective thymocyte development and perturbed homeostasis of T cells in STAT-induced STAT inhibitor-1/suppressors of cytokine signaling-1 transgenic mice. J Immunol 165: 1799-1806. PubMed: 10925257.
33. Federici M, Giustizieri ML, Scarponi C, Girolomoni G, Albanesi C, (2002) Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1. J Immunol 169: 434-442. PubMed: 12077274.
34. Madonna S, Scarponi C, De Pità O, Albanesi C, (2008) Suppressor of cytokine signaling 1 inhibits IFN-gamma inflammatory signaling in human keratinocytes by sustaining ERK1/2 activation. FASEB J 22: 3287-3297. doi:10.1096/fj.08-106831. PubMed: 18556463.
35. Albanesi C, Federici M, Giustizieri ML, Scarponi C, Girolomoni G, (2002) Suppressor of cytokine signaling-1 inhibits interferon-gamma-induced activation of human keratinocytes. Ann N Y Acad Sci 973: 79-82. doi:10.1111/j.1749-6632.2002.tb04610.x. PubMed: 12485838.
36. Hanada T, Kobayashi T, Chinen T, Saeki K, Takaki H, et al. (2006) IFNgamma-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice. J Exp Med 203: 1391-1397. doi:10.1084/jem.20060436. PubMed: 16717119.
37. Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, et al. (2001) SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 28: 29-35. doi:10.1038/ng0501-29. PubMed: 11326271.
38. Chen CY, Tsay W, Tang JL, Shen HL, Lin SW, et al. (2003) SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia. Genes Chromosomes Cancer 37: 300-305. doi:10.1002/gcc.10222. PubMed: 12759928.
39. To KF, Chan MW, Leung WK, Ng EK, Yu J, et al. (2004) Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line. Br J Cancer 91: 1335-1341. doi:10.1038/sj.bjc.6602133. PubMed: 15354212.
40. Zitzmann K, Brand S, De Toni EN, Baehs S, Göke B, et al. (2007) SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells. Cancer Res 67: 5025-5032. doi:10.1158/0008-5472.CAN-06-2575. PubMed: 17510435.
41. Lesinski GB, Zimmerer JM, Kreiner M, Trefry J, Bill MA, et al. (2010) Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells. BMC Cancer 10: 142.
42. Eichberger T, Sander V, Schnidar H, Regl G, Kasper M, et al. (2006) Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes. Genomics 87: 616-632. doi:10.1016/j.ygeno.2005.12.003. PubMed: 16434164.
43. Shimokawa T, Tostar U, Lauth M, Palaniswamy R, Kasper M, et al. (2008) Novel human glioma-associated oncogene 1 (GLI1) splice variants reveal distinct mechanisms in the terminal transduction of the hedgehog signal. J Biol Chem 283: 14345-14354. doi:10.1074/jbc.M800299200. PubMed: 18378682.
44. Ghali L, Wong ST, Green J, Tidman N, Quinn AG, (1999) Gli1 protein is expressed in basal cell carcinomas, outer root sheath keratinocytes and a subpopulation of mesenchymal cells in normal human skin. J Invest Dermatol 113: 595-599. doi:10.1046/j.1523-1747.1999.00729.x. PubMed: 10504446.
45. Regl G, Neill GW, Eichberger T, Kasper M, Ikram MS, et al. (2002) Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma. Oncogene 21: 5529-5539. doi:10.1038/sj.onc.1205748. PubMed: 12165851.
46. Ikram MS, Neill GW, Regl G, Eichberger T, Frischauf AM, et al. (2004) GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter. J Invest Dermatol 122: 1503-1509. doi:10.1111/j.0022-202X.2004.22612.x. PubMed: 15175043.
47. Li Z, Metze D, Nashan D, Müller-Tidow C, Serve HL, et al. (2004) Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma. J Invest Dermatol 123: 737-745. doi:10.1111/j.0022-202X.2004.23408.x. PubMed: 15373779.
48. Roth FP, Hughes JD, Estep PW, Church GM, (1998) Finding DNA regulatory motifs within unaligned noncoding sequences clustered by whole-genome mRNA quantitation. Nat Biotechnol 16: 939-945. doi:10.1038/nbt1098-939. PubMed: 9788350.
49. Winklmayr M, Schmid C, Laner-Plamberger S, Kaser A, Aberger F, et al. (2010) Non-consensus GLI binding sites in Hedgehog target gene regulation. BMC Mol Biol 11: 2. doi:10.1186/1471-2199-11-2. PubMed: 20070907.
50. Kinzler KW, Vogelstein B, (1990) The GLI gene encodes a nuclear protein which binds specific sequences in the human genome. Mol Cell Biol 10: 634-642. PubMed: 2105456.
51. Schroder K, Hertzog PJ, Ravasi T, Hume DA, (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75: 163-189. PubMed: 14525967.
52. Ramana CV, Chatterjee-Kishore M, Nguyen H, Stark GR, (2000) Complex roles of Stat1 in regulating gene expression. Oncogene 19: 2619-2627. doi:10.1038/sj.onc.1203525. PubMed: 10851061.
53. Agren M, Kogerman P, Kleman MI, Wessling M, Toftgård R, (2004) Expression of the PTCH1 tumor suppressor gene is regulated by alternative promoters and a single functional Gli-binding site. Gene 330: 101-114. doi:10.1016/j.gene.2004.01.010. PubMed: 15087129.
54. Kogerman P, Krause D, Rahnama F, Kogerman L, Undén AB, et al. (2002) Alternative first exons of PTCH1 are differentially regulated in vivo and may confer different functions to the PTCH1 protein. Oncogene 21: 6007-6016. doi:10.1038/sj.onc.1205865. PubMed: 12203113.
55. Teglund S, Toftgård R, (2010) Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim Biophys Acta 1805: 181-208. PubMed: 20085802.
56. Sanchez-Diaz PC, Burton TL, Burns SC, Hung JY, Penalva LO, (2008) Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy. BMC Cancer 8: 280. doi:10.1186/1471-2407-8-280. PubMed: 18826648.
57. Venkataraman S, Alimova I, Fan R, Harris P, Foreman N, et al. (2010) MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence. PLOS ONE 5: e10748. doi:10.1371/journal.pone.0010748. PubMed: 20574517.
58. Teider N, Scott DK, Neiss A, Weeraratne SD, Amani VM, et al. (2010) Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma. Neuro Oncol 12: 1244-1256. PubMed: 20847082.
59. Miller CH, Maher SG, Young HA, (2009) Clinical Use of Interferon-gamma. Ann N Y Acad Sci 1182: 69-79. doi:10.1111/j.1749-6632.2009.05069.x. PubMed: 20074276.
60. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, et al. (1998) Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A 95: 7556-7561. doi:10.1073/pnas.95.13.7556. PubMed: 9636188.
61. Lee CK, Rao DT, Gertner R, Gimeno R, Frey AB, et al. (2000) Distinct requirements for IFNs and STAT1 in NK cell function. J Immunol 165: 3571-3577. PubMed: 11034357.
62. Davey GM, Heath WR, Starr R, (2006) SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens 67: 1-9. doi:10.1111/j.1399-0039.2005.00532.x. PubMed: 16451196.
63. Umeda H, Ozaki N, Mizutani N, Fukuyama T, Nagasaki H, et al. (2010) Protective effect of hedgehog signaling on cytokine-induced cytotoxicity in pancreatic beta-cells. Exp Clin Endocrinol Diabetes 118: 692-698. doi:10.1055/s-0030-1254151. PubMed: 20533175.
64. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, et al. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431-442. doi:10.1016/S0092-8674(00)81288-X. PubMed: 8608597.
65. Kooy AJ, Tank B, Vuzevski VD, van Joost T, Prens EP, (1998) Expression of interferon-gamma receptors and interferon-gamma-induced up-regulation of intercellular adhesion molecule-1 in basal cell carcinoma; decreased expression of IFN-gamma R and shedding of ICAM-1 as a means to escape immune surveillance. J Pathol 184: 169-176. doi:10.1002/(SICI)1096-9896(199802)184:2. PubMed: 9602708.
66. Taylor RS, Griffiths CE, Brown MD, Swanson NA, Nickoloff BJ, (1990) Constitutive absence and interferon-gamma-induced expression of adhesion molecules in basal cell carcinoma. J Am Acad Dermatol 22: 721-726.
67. Scutti JA, Matsuo AL, Pereira FV, Massaoka MH, Figueiredo CR, et al. (2011) Role of SOCS-1 Gene on Melanoma Cell Growth and Tumor Development. Transl Oncol 4: 101-109. PubMed: 21461173.
68. Zhou J, Dudley ME, Rosenberg SA, Robbins PF, (2004) Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanoma. J Immunol 173: 7622-7629. PubMed: 15585890.
69. Raccurt M, Tam SP, Lau P, Mertani HC, Lambert A, et al. (2003) Suppressor of cytokine signalling gene expression is elevated in breast carcinoma. Br J Cancer 89: 524-532. doi:10.1038/sj.bjc.6601115. PubMed: 12888825.
70. Eichberger T, Kaser A, Pixner C, Schmid C, Klingler S, et al. (2008) GLI2-specific transcriptional activation of the bone morphogenetic protein/activin antagonist follistatin in human epidermal cells. J Biol Chem 283: 12426-12437. doi:10.1074/jbc.M707117200. PubMed: 18319260.
71. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, et al. (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33: 401-406. doi:10.1038/ng1117. PubMed: 12590264.
72. Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, et al. (2004) The zinc-finger transcription factor GLI2 antagonizes contact inhibition and differentiation of human epidermal cells. Oncogene 23: 1263-1274. doi:10.1038/sj.onc.1207240. PubMed: 14691458.
73. Bunt J, de Haas TG, Hasselt NE, Zwijnenburg DA, Koster J, et al. (2010) Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines. Mol Cancer Res 8: 1344-1357. doi:10.1158/1541-7786.MCR-09-0546. PubMed: 21047732.
74. Kasper M, Regl G, Eichberger T, Frischauf AM, Aberger F, (2007) Efficient manipulation of Hedgehog/GLI signaling using retroviral expression systems. Methods Mol Biol 397: 67-78. doi:10.1007/978-1-59745-516-9_6. PubMed: 18025714.
75. Martin KJ, Graner E, Li Y, Price LM, Kritzman BM, et al. (2001) High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood. Proc Natl Acad Sci U S A 98: 2646-2651. doi:10.1073/pnas.041622398. PubMed: 11226293.